[1]
2017. SAFETY, TOLERABILITY AND BIOEQUIVALENCE ASSESSMENT OF A DISPERSIBLE TABLET FORMULATION OF PYRAZINAMIDE. International Journal of Pharmaceutical Sciences and Drug Research. 9, 5 (Sep. 2017), 220–223. DOI:https://doi.org/10.25004/IJPSDR.2017.090503.